Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.52 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.52 |
| ▸ | AR | P10275 | 7/20 | 0.46 |
| ▸ | MAOA | P21397 | 4/20 | 0.46 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | EGFR | P00533 | 2/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL393816 | 1.00 | ALDH1A1 (0.61) | ALDH1A1KDM4EUSP2IMPDH2IMPDH1 | |
| SCHEMBL286644 | 0.88 | AR (0.53) | ALDH1A1KDM4EUSP2IMPDH2IMPDH1 | |
| SCHEMBL1395661 | 0.83 | MAOB (0.61) | ALDH1A1KDM4EUSP2MAOAMAOB | |
| SCHEMBL30475151 | 0.83 | MAOB (0.61) | ALDH1A1KDM4EUSP2MAOAMAOB | |
| SCHEMBL3578378 | 0.80 | XDH (0.51) | ALDH1A1KDM4EUSP2IMPDH2IMPDH1 | |
| SCHEMBL16952060 | 0.80 | KDM4E (0.39) | ALDH1A1KDM4EUSP2 | |
| SCHEMBL14661896 | 0.80 | KDM4E (0.39) | ALDH1A1KDM4EUSP2 | |
| SCHEMBL14661858 | 0.80 | PYCR1 (0.44) | ALDH1A1KDM4EUSP2 | |
| SCHEMBL392560 | 0.79 | MAOB (0.47) | ALDH1A1ARMAOAMAOBEGFR | |
| SCHEMBL1293570 | 0.79 | XDH (0.48) | MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4518974-A1 | IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | Interline Therapeutics, Inc. (US) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023239941-A1 | IMIDAZO(1,2-A)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | INTERLINE THERAPEUTICS INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2022226668-A1 | HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) | ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) | 2022-11-03 | — | — | WO | disclosed |